Clinical Trials Arena on MSN
Potentially “groundbreaking” FDA gene therapy pathway leaves key issues unresolved
A new FDA pathway could speed bespoke gene therapies, but key questions over scope and commercial viability remain.
To compete at iGEM, a sort of science Olympics, teens at a Georgia high school set their sights on finding a better way to ...
After releasing two gene-edited rice varieties in May this year, scientists are now focusing on developing GE varieties of ...
Cornell (NY, USA) researchers have found that a new DNA sequencing technology can be used to study how transposons move ...
Life's instructions are written in DNA, but it is the enzyme RNA polymerase II (Pol II) that reads the script, transcribing ...
With a new study in the journal Cell, researchers at Stanford University and Stockholm University have contributed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results